Estefany Pena Hilario, PA, RDMS, SG | |
Carretera #2 Km11.6, Bayamon, PR 00959-4924 | |
(787) 474-8282 | |
Not Available |
Full Name | Estefany Pena Hilario |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | Carretera #2 Km11.6, Bayamon, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659060119 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Estefany Pena Hilario, PA, RDMS, SG Ak16 Calle Ana, Bayamon, PR 00959-4924 Ph: (939) 267-8181 | Estefany Pena Hilario, PA, RDMS, SG Carretera #2 Km11.6, Bayamon, PR 00959-4924 Ph: (787) 474-8282 |
News Archive
Findings from a new study examining human and canine brain cancer cells suggest that cannabidiol could be a useful therapy for a difficult-to-treat brain cancer. Cannabidiol, or CBD, is a non-psychoactive chemical compound derived from marijuana.
Cancer is one of the hardest medical conditions to overcome, and for those who do so, the battle often does not stop at remission. Many cancers predispose patients to develop blood clots, particularly patients who are diagnosed at a late stage, which often complicates their treatment and reduces survival rates.
Camera-guided surgery through small incisions works better than conventional surgery for colon cancer and related diseases, at least in the short term recovery, a new review of previous studies confirms. In the long term, researchers found no difference between the two.
In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits.
› Verified 4 days ago